Grow Therapy
PrivateLast Round
Series D
Mar 3, 2026
Est. Valuation
$3B
Total Funding Raised
$331.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Grow Therapy is a mental health care company that provides a technology-enabled platform to connect patients with in-network therapists and psychiatrists while supporting independent providers with practice management tools.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Patient Engagement, Vertical SaaS, Revenue Cycle
Business Model
B2B2C
Customer Profile
Marketplace Commission, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Grow Therapy Comparables
Compare Grow Therapy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Headway | 94% | |
| Rula | 86% | |
| SonderMind | 84% |
Grow Therapy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 3, 2026 | ||||
| Series C | Apr 8, 2024 | ||||
| Series B | Sep 29, 2022 | ||||
| Series A | Sep 23, 2021 | ||||
| Seed | Oct 1, 2020 |
Key People
Founding team and executive leadership
Grow Therapy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Able Partners | Seed |
| Plus Capital | Series C |
| TCV | Series C, Series B |
| Gaingels | Seed |
| British Columbia Investment Management Corporation | Series D |
| TCV | Series A, Series C, Series D, Series B |
| Goldman Sachs Growth Equity | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Partnered with Amazon to offer mental health services to employees.
- Apr 18, 2026
Served hundreds of thousands of clients since February 2021.
Recent news
Latest coverage and updates
- acquiresSep 16, 2026
Grow Therapy acquires Tenor Therapy, Inc..
- launchesAug 20, 2026
Grow Therapy launched Compass Parenting on Aug 20th '26.
- is_developingAug 20, 2026
Grow Therapy is developing Compass Parenting on Aug 20th '26.
Grow Therapy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Grow Therapy's valuation, stock price, and market status.
Is Grow Therapy a public or private company?
Grow Therapy is a private company.
What is the current stock price of Grow Therapy?
Grow Therapy is a private company with no public stock price. No recent secondary market data is available.
How much is Grow Therapy worth (valuation)?
Grow Therapy's valuation is estimated at $3.0B based on funding round data.
Can I buy Grow Therapy stock?
Grow Therapy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Grow Therapy's last funding round?
Grow Therapy's most recent funding round was Series D on March 3, 2026.
Who are the main investors in Grow Therapy?
Key investors in Grow Therapy include TCV, TCV, Goldman Sachs Growth Equity, Sequoia Capital, Goldman Sachs Growth Equity.
Will Grow Therapy IPO soon?
No public IPO plans have been announced for Grow Therapy.
How can I track Grow Therapy secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Grow Therapy's secondary market activity and sign up for updates.